首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1532554

聚合酶炼式反应 (PCR) 消耗品市场、副产品、技术、应用、最终用途 - 全球预测

Polymerase Chain Reaction (PCR) Consumables Market, By Product, Technology, Application, End-use - Global Forecast

出版日期: 2024年05月23日 | 出版商:

Global Market Insights Inc. | 英文 175 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在对传染病管理的日益关注和实验室基础设施改善的推动下，全球聚合酶链反应 (PCR) 消耗品市场在 2024 年至 2032 年间将以 4.8% 的复合年增长率扩张。对 COVID-19 等传染病进行准确、快速诊断测试的需求激增，增加了对 PCR 耗材的需求。此外，实验室基础设施（包括自动化和高通量系统）的进步提高了 PCR 检测的效率和可扩展性。这些因素共同促进了 PCR 耗材的日益普及，推动了市场扩张和创新。

例如，2024 年 4 月，Eppendorf 推出了 BioBased PCR 板，增强了实验室的可持续性。 twin.tec(R) Trace 板易于自动化操作，由生物基原料製成，具有 96 个孔，并提供半透明透明版本，扩展了 Eppendorf 的产品组合。透过扩大此类创新产品的产品组合，Eppendorf 正在解决永续性问题并增强 PCR 耗材的功能和吸引力，这可能会推动市场成长并在行业中树立新标准。

整个聚合酶链反应 (PCR) 耗材产业根据产品、应用、最终用途和地区进行划分。

由于製药和生物技术公司越来越多地外包研发活动，到 2032 年，合约研究组织部门将占据显着的市场份额。 CRO 提供专业知识、先进技术和经济高效的解决方案，推动了临床试验、药物开发和基因研究中对 PCR 耗材的需求。为了提高效率和专注于核心能力而进行的外包趋势不断增长，进一步提升了 CRO 在聚合酶炼式反应 (PCR) 耗材市场中的地位。

由于 PCR 微孔板在高通量测试和自动化领域的广泛应用，到 2032 年，PCR 微孔板领域将经历显着的改善。这些微孔板有助于同时处理大量样品，从而提高实验室的效率和准确性。它们与各种 PCR 机器的兼容性和易用性使其在诊断、研究和临床应用中必不可少。对快速和大规模检测的需求不断增长，特别是在传染病背景下，进一步推动了 PCR 微孔板领域的突出地位。

在先进的医疗基础设施和大量研发投资的推动下，欧洲 PCR 耗材产业将在 2024 年和 2032 年实现显着的复合年增长率。该地区先进诊断技术的高采用率和领先生物技术公司的存在推动了市场的成长。此外，政府支持基因组研究的措施和传染病流行率的不断上升也增加了对 PCR 耗材的需求。欧洲对创新和卓越医疗保健的重视将使其成为全球聚合酶炼式反应 (PCR) 耗材市场的重要贡献者。

产业生态系统分析
产业影响力
- 成长动力
  - 传染病流行率不断上升
  - 对分子诊断的需求不断增长
  - 生命科学研究投资不断增加
  - 瓣膜性心臟病的盛行率不断增加
- 产业陷阱与挑战
  - 监管和品质合规要求
  - 测定设计和优化的复杂性
成长潜力分析
技术景观
监管环境
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
PCR管
PCR 微孔板
盖子/盖子
其他产品

第 6 章：市场估计与预测：按技术分类，2021 - 2032 年

主要趋势
实时萤光定量PCR
数位PCR
传统PCR

第 7 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
研究
临床

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
医院和临床诊断实验室
製药和生物技术公司
学术及研究机构
合约研究组织 (CRO)
其他最终用户

第 9 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

Abbott Laboratories
Agilent Technologies, Inc.
Analytik Jena AG
Becton, Dickinson and Company
Bioer Technology Co., Ltd.
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Merck KGaA
New England Biolabs, Inc.
Promega Corporation
QIAGEN N.V.
Takara Bio Inc.
Thermo Fisher Scientific, Inc.

简介目录

Product Code: 9609

Global Polymerase Chain Reaction (PCR) Consumables Market will expand at a 4.8% CAGR between 2024 and 2032, fueled by increased focus on infectious disease management and improved laboratory infrastructure. The surge in demand for accurate and rapid diagnostic tests for infectious diseases such as COVID-19 boosts the need for PCR consumables. Moreover, advancements in laboratory infrastructure, including automation and high-throughput systems, enhance the efficiency and scalability of PCR testing. These factors collectively contribute to the growing adoption of PCR consumables, fueling market expansion and innovation.

For instance, in April 2024, Eppendorf launched BioBased PCR Plates, enhancing laboratory sustainability. The twin.tec(R) Trace Plates, automation-friendly and made from biobased feedstock, feature 96 wells and are available in translucent clear, expanding Eppendorf's portfolio. By expanding its portfolio with such innovative products, Eppendorf is addressing sustainability concerns and enhancing the functionality and appeal of PCR consumables, which could drive market growth and set new standards in the industry.

The overall polymerase chain reaction (PCR) consumables industry is divided based on product, application, end-use, and region.

The contract research organization segment will secure a noteworthy market presence by 2032, attributed to the increasing outsourcing of research and development activities by pharmaceutical and biotechnology companies. CROs offer specialized expertise, advanced technologies, and cost-effective solutions, driving their demand for PCR consumables in clinical trials, drug development, and genetic research. The growing trend of outsourcing to enhance efficiency and focus on core competencies further boosts the prominence of CROs in the polymerase chain reaction (PCR) consumables market.

The PCR microplates segment will undergo a notable upturn by 2032 due to their widespread use in high throughput testing and automation. These microplates facilitate the simultaneous processing of numerous samples, enhancing efficiency and accuracy in laboratories. Their compatibility with various PCR machines and ease of use make them essential in diagnostic, research, and clinical applications. The growing demand for rapid and large-scale testing, particularly in the context of infectious diseases, further drives the prominence of the PCR microplates segment.

Europe PCR consumables industry will record a remarkable CAGR during 2024 and 2032, propelled by advanced healthcare infrastructure and significant investment in research and development. The region's high adoption rate of advanced diagnostic technologies and the presence of leading biotechnology companies drive market growth. Additionally, government initiatives supporting genomic research and the escalating prevalence of contagious diseases bolster demand for PCR consumables. Europe's emphasis on innovation and healthcare excellence will establish it as a vital contributor to the global polymerase chain reaction (PCR) consumables market.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of infectious diseases
  - 3.2.1.2 Growing demand for molecular diagnostics
  - 3.2.1.3 Rising investments in life sciences research
  - 3.2.1.4 Increasing prevalence of valvular heart diseases
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Regulatory and quality compliance requirements
  - 3.2.2.2 Complexity of assay design and optimization
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 PCR tubes
5.3 PCR microplates
5.4 Cap/lids
5.5 Other products

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Real time PCR
6.3 Digital PCR
6.4 Traditional PCR

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Research
7.3 Clinical

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals and clinical diagnostic laboratories
8.3 Pharmaceutical and biotechnology companies
8.4 Academic and research institutes
8.5 Contract research organizations (CROs)
8.6 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa